ATE349525T1 - Histamine und serotonine bindende moleküle - Google Patents

Histamine und serotonine bindende moleküle

Info

Publication number
ATE349525T1
ATE349525T1 AT98955786T AT98955786T ATE349525T1 AT E349525 T1 ATE349525 T1 AT E349525T1 AT 98955786 T AT98955786 T AT 98955786T AT 98955786 T AT98955786 T AT 98955786T AT E349525 T1 ATE349525 T1 AT E349525T1
Authority
AT
Austria
Prior art keywords
histamine
serotonin
molecules
binding molecules
possess
Prior art date
Application number
AT98955786T
Other languages
English (en)
Inventor
Patricia Ann Nuttall
Guido Christian Paesen
Original Assignee
Evolutec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9725046.8A external-priority patent/GB9725046D0/en
Priority claimed from GBGB9813917.3A external-priority patent/GB9813917D0/en
Application filed by Evolutec Ltd filed Critical Evolutec Ltd
Application granted granted Critical
Publication of ATE349525T1 publication Critical patent/ATE349525T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98955786T 1997-11-26 1998-11-26 Histamine und serotonine bindende moleküle ATE349525T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9725046.8A GB9725046D0 (en) 1997-11-26 1997-11-26 Histamine binding molecules
GBGB9813917.3A GB9813917D0 (en) 1998-06-26 1998-06-26 Histamine and serotonin binding molecules

Publications (1)

Publication Number Publication Date
ATE349525T1 true ATE349525T1 (de) 2007-01-15

Family

ID=26312664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98955786T ATE349525T1 (de) 1997-11-26 1998-11-26 Histamine und serotonine bindende moleküle

Country Status (12)

Country Link
EP (1) EP1034273B1 (de)
JP (1) JP2002508927A (de)
CN (1) CN1325645C (de)
AT (1) ATE349525T1 (de)
AU (1) AU763299B2 (de)
BR (1) BR9815056A (de)
CA (1) CA2309809A1 (de)
DE (1) DE69836761D1 (de)
NZ (1) NZ504753A (de)
PL (1) PL340728A1 (de)
SK (1) SK7912000A3 (de)
WO (1) WO1999027104A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920674D0 (en) * 1999-09-01 1999-11-03 Evolutec Limited Treatment of conjunctivitis
GB9920673D0 (en) * 1999-09-01 1999-11-03 Evolutec Limited Treatment of allergic rhinitis
GB0307544D0 (en) * 2003-04-01 2003-05-07 Evolutec Ltd Treatment method
US9226489B2 (en) 2011-03-18 2016-01-05 Ecolab Usa Inc. Heat system for killing pests
GB201720505D0 (en) * 2017-12-08 2018-01-24 Volution Immuno Pharmaceuticals Sa Methods for treatment of neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996011271A1 (en) * 1994-10-07 1996-04-18 Heska Corporation Novel ectoparasite saliva proteins and apparatus to collect such proteins
EP0906425B1 (de) * 1996-05-18 2005-03-02 Oxford Vacs Ltd. Vasoaktive, aminbindende moleküle

Also Published As

Publication number Publication date
JP2002508927A (ja) 2002-03-26
AU1251199A (en) 1999-06-15
NZ504753A (en) 2002-11-26
PL340728A1 (en) 2001-02-26
CN1286726A (zh) 2001-03-07
WO1999027104A1 (en) 1999-06-03
DE69836761D1 (de) 2007-02-08
EP1034273B1 (de) 2006-12-27
BR9815056A (pt) 2000-10-03
AU763299B2 (en) 2003-07-17
CN1325645C (zh) 2007-07-11
CA2309809A1 (en) 1999-06-03
EP1034273A1 (de) 2000-09-13
SK7912000A3 (en) 2000-12-11

Similar Documents

Publication Publication Date Title
EA200200647A1 (ru) АГОНИСТЫ β2-АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
PT912176E (pt) Utilizacao de amidas do acido piridil-alcanoico piridil-alcenoico e/ou piridil-alcinico para o tratamento de tumores ou para imunossupressao
ATE409181T1 (de) Proteomimetische verbindungen und verfahren
ATE425989T1 (de) Proteinreinigungsverfahren
DE50012863D1 (de) Strukturprotein von adeno-assoziiertem virus mit veränderten chromatographischen eigenschaften
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
BR0211926A (pt) agentes para realçar a resposta imune
SE9603068D0 (sv) Process for purifying a protein
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
ATE373016T1 (de) Induktion von immunologischer toleranz gegen einen therapeutischen antikörper durch varianten des therapeutischen antikörpers
BR0211200A (pt) Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
ATE484587T1 (de) Ldcam genannte moleküle
EA200100012A1 (ru) Мостиковые инденопирролокарбазолы
DE69837760D1 (de) Proteinreinigung mittels chromatographie und darauffolgende filtration auf beladener schicht
BR0209990A (pt) Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
EA200401453A1 (ru) Молекулы распознавания на клеточной поверхности, содержащие иммуноглобулиновый домен
BR0312521A (pt) Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado
WO2003033658A3 (en) Neutrokine-alpha and neutrokine-alpha splice variant
ATE206139T1 (de) Verfahren zur modifizierung der stabilität von antikörpern
DK1368054T3 (da) Anvendelse af neurale trådproteiner til behandling af tumorer
HUP0100668A2 (hu) Virulenciával kapcsolatos nukleinsavszekvenciák és alkalmazásuk
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
WO2003087138A3 (en) Methods for identifying polypeptide factors interacting with rna
DE69836761D1 (de) Histamine und serotonine bindende moleküle
ATE333469T1 (de) Verfahren zur reinigung hochanionischer proteine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties